Genelux Corporation
Clinical trials sponsored by Genelux Corporation, explained in plain language.
-
Virus therapy shows promise in reversing chemo resistance for ovarian cancer patients
Disease control Recruiting nowThis study tests a new treatment called Olvi-Vec, a virus that targets cancer cells, followed by chemotherapy and a targeted drug (bevacizumab) in women with ovarian cancer that no longer responds to platinum-based chemo. About 186 participants will receive either the new combina…
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated May 01, 2026 19:27 UTC
-
Cancer-Fighting virus shows promise in lung cancer trial
Disease control Recruiting nowThis study tests a new approach for people with advanced lung cancer whose disease has worsened after initial treatment. Participants receive an experimental virus therapy (Olvi-Vec) followed by chemotherapy and an immunotherapy drug, or standard chemo alone. The goal is to see i…
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC